Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
12.18
+0.10 (0.83%)
Dec 20, 2024, 4:00 PM EST - Market closed
Intellia Therapeutics Analyst Ratings
Total Analysts
17
Consensus Rating
Buy
Price Target
$56.63
Upside
+364.94%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $90 | Strong Buy | Maintains | $90 | +638.92% | Nov 19, 2024 |
Wells Fargo | Wells Fargo | Buy Maintains $80 → $70 | Buy | Maintains | $80 → $70 | +474.71% | Nov 18, 2024 |
Wedbush | Wedbush | Hold Reiterates $14 | Hold | Reiterates | $14 | +14.94% | Nov 18, 2024 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $88 → $91 | Strong Buy | Maintains | $88 → $91 | +647.13% | Nov 18, 2024 |
Oppenheimer | Oppenheimer | Buy Maintains $70 → $60 | Buy | Maintains | $70 → $60 | +392.61% | Nov 11, 2024 |
Barclays | Barclays | Buy Maintains $76 → $55 | Buy | Maintains | $76 → $55 | +351.56% | Nov 8, 2024 |
Citigroup | Citigroup | Hold Maintains $25 → $19 | Hold | Maintains | $25 → $19 | +55.99% | Oct 25, 2024 |
Goldman Sachs | Goldman Sachs | Hold Maintains $31 → $20 | Hold | Maintains | $31 → $20 | +64.20% | Oct 25, 2024 |
Baird | Baird | Hold Maintains $24 → $18 | Hold | Maintains | $24 → $18 | +47.78% | Oct 25, 2024 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $94 → $88 | Strong Buy | Maintains | $94 → $88 | +622.50% | Oct 24, 2024 |
RBC Capital | RBC Capital | Buy Reiterates $54 | Buy | Reiterates | $54 | +343.35% | Sep 19, 2024 |
Jones Trading | Jones Trading | Strong Buy Initiates $41 | Strong Buy | Initiates | $41 | +236.62% | Sep 17, 2024 |
Stifel | Stifel | Strong Buy Maintains $80 → $64 | Strong Buy | Maintains | $80 → $64 | +425.45% | Sep 11, 2024 |
JP Morgan | JP Morgan | Buy Maintains $61 → $55 | Buy | Maintains | $61 → $55 | +351.56% | Aug 12, 2024 |
RBC Capital | RBC Capital | Buy Maintains $60 → $54 | Buy | Maintains | $60 → $54 | +343.35% | Aug 9, 2024 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $73 | Strong Buy | Maintains | $73 | +499.34% | Jun 27, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.